PMC:7228307 / 52334-52502
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1044 | 74-78 | Gene | denotes | FcγR | Gene:2213 |
| 1049 | 132-142 | Chemical | denotes | teplizumab | MESH:C502540 |
| 1050 | 147-157 | Chemical | denotes | spesolimab |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T885 | 74-76 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
LitCovid-sample-Pubtator
| Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
|---|---|---|---|---|---|
| 1044 | 74-78 | Gene | denotes | FcγR | Gene:2213 |
| 1049 | 132-142 | Chemical | denotes | teplizumab | MESH:C502540 |
| 1050 | 147-157 | Chemical | denotes | spesolimab |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T298 | 0-168 | Sentence | denotes | It is often referred to as the “LALA mutation” and effectively eliminates FcγR binding by more than 100 fold104, 105 and is used in teplizumab and spesolimab (Table 4). |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T298 | 0-168 | Sentence | denotes | It is often referred to as the “LALA mutation” and effectively eliminates FcγR binding by more than 100 fold104, 105 and is used in teplizumab and spesolimab (Table 4). |